Actively Recruiting
Open-Label Single-Arm Trial Evaluating Bimekizumab Pharmacokinetics and Safety in Children Aged 2 to Under 18 With Active Enthesitis-Related and Juvenile Psoriatic Arthritis
Led by UCB Biopharma SRL · Updated on 2026-10-23
40
Participants Needed
23
Research Sites
120 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the levels of plasma bimekizumab after subcutaneous administration in children aged 2 to under 18 years with active juvenile idiopathic arthritis subtypes, specifically enthesitis-related arthritis including juvenile-onset ankylosing spondylitis and juvenile psoriatic arthritis. This Phase 3 open-label trial aims to understand the pharmacokinetics and safety of bimekizumab in this pediatric population. Participants will receive weight-based doses of bimekizumab at scheduled times. The study is a single-arm design where all participants receive the investigational drug. The initial treatment period lasts up to 16 weeks, during which plasma concentrations of bimekizumab are monitored closely. Following this, there is a safety follow-up period lasting up to 141 weeks to track treatment-emergent adverse events and other safety parameters. Throughout the study, participants will undergo various assessments including vital signs, blood tests for biochemistry and hematology, growth measurements, and evaluations for injection site pain. Disease activity and response are measured using standardized pediatric arthritis scores. Researchers will also monitor for antibodies against bimekizumab and record any serious or specific safety events. The total participation may extend over several years to ensure long-term safety and treatment effects are observed.
CONDITIONS
Brief Title
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Research Team
U
UCB Cares
U
UCB Cares
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here